Effective substance and mechanism of Ziziphi Spinosae Semen extract in treatment of insomnia based on serum metabolomics and network pharmacology.
10.19540/j.cnki.cjcmm.20210922.702
- Author:
Zhen-Hua BIAN
1
;
Wen-Ming ZHANG
2
;
Jing-Yue TANG
2
;
Qian-Qian FEI
2
;
Min-Min HU
2
;
Xiao-Wei CHEN
2
;
Lian-Lin SU
3
;
Cheng-Hao FEI
3
;
De JI
3
;
Chun-Qin MAO
3
;
Huang-Jin TONG
3
;
Tu-Lin LU
3
;
Xiao-Hang YUAN
2
Author Information
1. Department of Pharmacy, Wuxi Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine Wuxi 214071, China College of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023, China.
2. Department of Pharmacy, Wuxi Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine Wuxi 214071, China.
3. College of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023, China.
- Publication Type:Journal Article
- Keywords:
Ziziphi Spinosae Semen;
biomarkers;
effective substance;
endogenous metabolites;
insomnia;
metabolic pathways;
metabolomics;
network pharmacology
- MeSH:
Animals;
Chromatography, High Pressure Liquid;
Drugs, Chinese Herbal/chemistry*;
Metabolomics;
Network Pharmacology;
Rats;
Seeds/chemistry*;
Sleep Initiation and Maintenance Disorders/drug therapy*;
Tandem Mass Spectrometry;
Ziziphus/chemistry*
- From:
China Journal of Chinese Materia Medica
2022;47(1):188-202
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to study the effective substance and mechanism of Ziziphi Spinosae Semen extract in the treatment of insomnia based on serum metabolomics and network pharmacology. The rat insomnia model induced by p-chlorophenylalanine(PCPA) was established. After oral administration of Ziziphi Spinosae Semen extract, the general morphological observation, pentobarbital sodium-induced sleep test, and histopathological evaluation were carried out. The potential biomarkers of the extract in the treatment of insomnia were screened by ultra-high performance liquid chromatography-mass spectrometry(UHPLC-MS) combined with multivariate analysis, and the related metabolic pathways were further analyzed. The "component-target-pathway" network was constructed by ultra-high performance liquid chromatography coupled with quadrupole-Exactive mass spectrometry(UHPLC-Q-Exactive-MS/MS) combined with network pharmacology to explore the effective substances and mechanism of Ziziphi Spinosae Semen in the treatment of insomnia. The results of pentobarbital sodium-induced sleep test and histopathological evaluation(hematoxylin and eosin staining) showed that Ziziphi Spinosae Semen extract had good theraputic effect on insomnia. A total of 21 endogenous biomarkers of Ziziphi Spinosae Semen extract in the treatment of insomnia were screened out by serum metabolomics, and the metabolic pathways of phenylalanine, tyrosine and tryptophan biosynthesis, phenylalanine metabolism, and nicotinate and nicotinamide metabolism were obtained. A total of 34 chemical constituents were identified by UHPLC-Q-Exactive-MS/MS, including 24 flavonoids, 2 triterpenoid saponins, 4 alkaloids, 2 triterpenoid acids, and 2 fatty acids. The network pharmacological analysis showed that Ziziphi Spinosae Semen mainly acted on target proteins such as dopamine D2 receptor(DRD2), 5-hydroxytryptamine receptor 1 A(HTR1 A), and alpha-2 A adrenergic receptor(ADRA2 A) in the treatment of insomnia. It was closely related to neuroactive ligand-receptor interaction, serotonergic synapse, and calcium signaling pathway. Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia. This study revealed that Ziziphi Spinosae Semen extract treated insomnia through multiple metabolic pathways and the overall correction of metabolic disorder profile in a multi-component, multi-target, and multi-channel manner. Briefly, this study lays a foundation for further research on the mechanism of Ziziphi Spinosae Semen in treating insomnia and provides support for the development of innovative Chinese drugs for the treatment of insomnia.
